Home › Barclays Capital Increases Eli Lilly & Co. Price Target to $58.00
 

Keywords :   


Barclays Capital Increases Eli Lilly & Co. Price Target to $58.00

2013-07-28 06:19:29| Biotech - Topix.net

The firm currently has an "equal weight" rating on the stock. Barclays Capital's price objective indicates a potential upside of 8.70% from the company's current price.

Tags: to price capital target

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
15.11171
15.11 3FLYOVER
15.11 PSA8 - 1ed
15.11DMC RAVEN 18g
15.11LOVE or DEAD Blu-ray
15.11 HSGI SURE-GRIP PADDED BELT a-tacs au
15.11 BOUNTY HUNTER
15.11
More »